Dimethyl terephthalate | CAS:120-61-6

We serve Dimethyl terephthalate CAS:120-61-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Dimethyl terephthalate

Chemical Name:Dimethyl terephthalate
CAS.NO:120-61-6
Synonyms:Dimethyl terephthalate
1,4-Benzenedicarboxylic acid, dimethyl ester
Terephthalic Acid Dimethyl Ester
DMT
dimethyl benzene-1,4-dicarboxylate
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 285.0±8.0 °C at 760 mmHg
Melting Point 140 °C
Molecular Formula C10H10O4
Molecular Weight 194.184
Flash Point 148.0±7.9 °C
 
Specification:
Appearance:White Chunks 
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Pigment yellow 155 Intermediate



Contact us for information like Dimethyl terephthalate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,dimethyl benzene-1,4-dicarboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,DMT Use and application,Dimethyl terephthalate technical grade,usp/ep/jp grade.


Related News: The government is leveraging its large patient population to push non-domestic drugs companies to cut prices to their lowest level globally.Allylboronic acid pinacol ester manufacturer The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.(R)-[N-3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl azide supplier The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.1-Chloro-5-iodopentane vendor Indonesia is suspending its visa-free travel for Chinese citizens and barring passengers who have visited mainland China in the past 14 days.Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.